November 7, 2017 Blue Diesel Data Science launched General Inquiry, the second dashboard for its pharmaceutical insight tool VisionaryRX. This latest dashboard is designed to expand on existing capabilities by providing deeper insight into drug molecules, forms, strengths, manufacturers, drug master filings, clinical trials, application holders, Medicaid and those multiple relationships.
VisionaryRX is comprised of over 40 million rows of data from 9 different major sources with open architecture for expansion. Data is cleansed, consolidated and presented in related dashboards for research. The typical manual and error prone process of gathering information for drug molecules is removed. What can be done in seconds in VisionaryRX would take days or weeks if done manually. The video below is a quick walkthrough on how you can use it.
The General Inquiry dashboard is available to partners and developers in the beta program at a reduced cost. Visit our VRX page for timelines, more information or to sign up for VisionaryRX programs.
Be a Development Partner
Future iterations of VisionaryRX dashboards and views will be released through multiple development phases. Please contact us using the form below or email VisionaryRXDevelopment@bluedieseldata.com if you or your organization is interested in development partnerships.